First real-world study on the effectiveness and tolerability of rimegepant for acute migraine therapy in Chinese patients Authors Xiaoyan Li (ORCID: https://orcid.org/0000-0002-8874-5634) Wei Qiao (ORCID: https://orcid.org/0000-0001-5287-9916) Shuo Zhu (ORCID: https://orcid.org/0000-0002-3000-1536) Peijian Huang Mengyue Niu (ORCID: https://orcid.org/0000-0002-9714-593X) Weihong Yuan (ORCID: https://orcid.org/0000-0002-6514-4342) Wenyan Kang (ORCID: https://orcid.org/0000-0001-7527-7512) Xiaodan Wang (ORCID: https://orcid.org/0009-0003-0039-7669) Jianzhou Yan Shengyuan Yu Wenli Xu (ORCID: https://orcid.org/0009-0000-1458-4797) Huizhu Zhong Jun Liu (ORCID: https://orcid.org/0000-0003-1179-7126) Yang Zhao (ORCID: https://orcid.org/0000-0002-3883-4997) Institutions China Pharmaceutical University (CN) Ruijin Hospital (CN) Chinese PLA General Hospital (CN) Hainan General Hospital (CN) Qiannan Normal College For Nationalities (CN) Hainan Medical University (CN) Hainan Tropical Ocean University (CN) Publication Details Journal The Journal of Headache and Pain Published 2024-09-27 DOI https://doi.org/10.1186/s10194-024-01873-5 Citations 4 Primary Topic Migraine and Headache Studies Type article Field-Weighted Citation Impact 1.54 Explore the Global Research Space Interactive Map